Interplay between membrane lipid peroxidation, transglutaminase activity, and Cyclooxygenase 2 expression in the tissue adjoining to breast cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Cellular Physiology

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1002/jcp.22874PMID 21678409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis.

  2011influential reference
• Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

  2011cited by this paper
• Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

  2011cited by this paper
• Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

  2010cited by this paper
• γ-Glutamyl 16-diaminopropane derivative of vasoactive intestinal peptide: a potent anti-oxidative agent for human epidermoid cancer cells

  2010cited by this paper
• Overexpression of the novel human gene, UBE2Q2, in breast cancer.

  2010cited by this paper
• The lipid peroxidation in breast cancer patients.

  2010cited by this paper
• The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

  2010cited by this paper
• The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

  2010cited by this paper
• NO to breast: when, why and why not?

  2010influential reference
• SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination*

  2010cited by this paper
• Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues.

  2009cited by this paper
• Plasma malondialdehyde levels and CXCR4 expression in peripheral blood cells of breast cancer patients

  2009cited by this paper
• Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion

  2009cited by this paper
• A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells.

  2009cited by this paper
• Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

  2008cited by this paper
• Understanding the immunoangiostatic CXC chemokine network.

  2008cited by this paper
• Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target.

  2007influential reference
• Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells

  2007cited by this paper
• Lipid peroxidation and total antioxidant status in patients with breast cancer

  2007cited by this paper
• Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis

  2007cited by this paper
• Tissue transglutaminase and the stress response

  2007cited by this paper
• Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system.

  2006cited by this paper
• Biomarkers of oxidative damage in human disease.

  2006influential reference
• Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer

  2006cited by this paper
• Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages

  2006cited by this paper
• Type 2 transglutaminase and cell death.

  2005cited by this paper
• Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation.

  2005cited by this paper
• Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling

  2005cited by this paper
• Oxidative stress in breast cancer

  2005cited by this paper
• Ubiquitin-binding domains

  2005cited by this paper
• Transglutaminase 2 in the balance of cell death and survival

  2005cited by this paper
• Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.

  2004cited by this paper
• Ubiquitin‐dependent lysosomal degradation of the HNE‐modified proteins in lens epithelial cells

  2004influential reference
• Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER‐negative, but not ER‐positive, breast cancer

  2004cited by this paper
• Lipid peroxidation, free radical production and antioxidant status in breast cancer

  2004cited by this paper
• Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer.

  2003cited by this paper
• Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.

  2003cited by this paper
• Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer.

  2003cited by this paper
• Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast.

  2002cited by this paper
• Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.

  2002cited by this paper
• Plasma malondialdehyde (MDA) levels in breast and lung cancer patients

  2001cited by this paper
• Evaluation of Oxidative Stress in Patients with Cancer

  2001cited by this paper
• 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression.

  2000influential reference
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Honey and cancer: from traditional medicine to modern adjuvant therapy.

  2026cites this paper
• Effects of Pervari Honey from Türkiye on Proliferation, Oxidative Stress, and Apoptosis of Human Breast Cancer Cells

  2024cites this paper
• Understanding the Anticancer Properties of Honey

  2024cites this paper
• Transglutaminase 2 in breast cancer metastasis and drug resistance

  2024cites this paper
• The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2

  2021cites this paper
• A comparative assessment of anti-inflammatory, anti-oxidant and anti-bacterial activities of hybrid and indigenous varieties of pumpkin (Cucurbita maxima Linn.) seed oil

  2020cites this paper
• Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype

  2019cites this paper
• Honey and cancer: A mechanistic review.

  2019cites this paper
• Tissue Transglutaminase 2 as a Predictive and Prognostic Factor: A Pilot Study of Neoadjuvant Therapy in Women with Breast Cancer

  2017cites this paper
• Transglutaminase 2 in cancer.

  2015cites this paper
• Effects of Honey and Its Mechanisms of Action on the Development and Progression of Cancer

  2014cites this paper
• Oxidative Medicine and Cellular Longevity

  2014cites this paper
• EVALUATION OF NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN SERUM OF EGYPTIAN PATIENTS WITH BLADDER AND RENAL TUMORS: POTENTIAL USE AS MEDICINAL BIOMARKERS

  2014cites this paper
• Evidence in Support of Potential Applications of Lipid Peroxidation Products in Cancer Treatment

  2013cites this paper
• Automation of Methods for Determination of Lipid Peroxidation

  2012cites this paper